Showing results (51-60 of 424) with videos related to
Sort By:
Pageof 43
JCO Precision Oncology|February 21, 2024
Targeting All BRAF Alterations: The (Re)-Search ContinuesDeepak Bhamidipati, Andrew Pellatt, Vivek SubbiahExperimental Hematology & Oncology|September 23, 2014
Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to boneAmol Takalkar, Scott Adams, Vivek SubbiahTargeted Oncology|May 26, 2026
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Knowledge Is PowerVivek Subbiah, Martin Dietrich, Xiuning LeNPJ Precision Oncology|March 4, 2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancerVivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, et al.Advances in Experimental Medicine and Biology|June 14, 2014
Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223Peter M Anderson, Vivek Subbiah, Eric RohrenCancer Journal (Sudbury, Mass.)|November 16, 2022
Evolving Landscape of Antibody Drug Conjugates in LymphomaRishab Prakash, Vivek Subbiah, Swaminathan P IyerBMJ Case Reports|April 25, 2019
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biologyKalevi Kairemo, Wei-Lien Wang, Vivek SubbiahCancer|March 22, 2023
Top advances of the year: Precision oncologyAakash Desai, Neha K Reddy, Vivek SubbiahCancer Discovery|April 4, 2024
A Vision for Democratizing Next-Generation Oncology Clinical TrialsVivek Subbiah, Denis Horgan, Ishwaria M SubbiahTrends in Cancer|October 3, 2020
From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision ParadigmJacob J Adashek, Vivek Subbiah, Razelle KurzrockPageof 43